End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
80.99 CNY | +5.37% | +5.73% | -30.24% |
Business Summary
Number of employees: 9,788
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Commercialization
65.3
%
| 7,587 | 74.0 % | 5,112 | 65.3 % | -32.61% |
Clinical and Pre-clinical
19.3
%
| 1,666 | 16.2 % | 1,507 | 19.3 % | -9.56% |
New Business
15.3
%
| 996 | 9.7 % | 1,199 | 15.3 % | +20.42% |
Other
0.1
%
| 6 | 0.1 % | 6 | 0.1 % | +0.08% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Overseas
81.1
%
| 8,691 | 84.7 % | 6,344 | 81.1 % | -27.01% |
China
18.9
%
| 1,564 | 15.3 % | 1,481 | 18.9 % | -5.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rui Yang
CEO | Chief Executive Officer | 47 | 01/99/01 |
Hao Hong
CEO | Chief Executive Officer | 68 | 07/98/07 |
Elut Hsu
PSD | President | - | 01/97/01 |
Xinhui Hu
CTO | Chief Tech/Sci/R&D Officer | 51 | 20/22/20 |
Da Zhang
COO | Chief Operating Officer | 43 | 01/18/01 |
James Gage
CTO | Chief Tech/Sci/R&D Officer | 60 | 18/11/18 |
Liang Hong
BRD | Director/Board Member | 50 | 01/98/01 |
Chang Liang Yu
IRC | Investor Relations Contact | 39 | 28/17/28 |
Xiaolian Huang
PRN | Corporate Officer/Principal | 50 | - |
Ying Wei Jiang
PRN | Corporate Officer/Principal | 49 | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 68 | 07/98/07 |
Rui Yang
CEO | Chief Executive Officer | 47 | 01/99/01 |
Xin Yi Hou
BRD | Director/Board Member | 64 | 29/02 |
Kar Chung Lee
BRD | Director/Board Member | 43 | 16/21/16 |
Ye Song
BRD | Director/Board Member | 63 | 18/11/18 |
Liang Hong
BRD | Director/Board Member | 50 | 01/98/01 |
Ting Zhang
BRD | Director/Board Member | 38 | 05/14/05 |
Shan Shan Di
BRD | Director/Board Member | 38 | 31/17/31 |
Da Zhang
COO | Chief Operating Officer | 43 | 01/18/01 |
Jing Yi Hou
BRD | Director/Board Member | 41 | 01/07/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,553,260 | 27,553,260 ( 100.00 %) | 0 | 60.56 % |
Stock B | 1 | 348,840,365 | 200,382,332 ( 57.44 %) | 6,922,092 ( 1.984 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
4,429,800 | 1.35% | 52,735,041 $ |
Company contact information
Asymchem Laboratories (Tianjin) Co., Ltd.
71 7th Street Tianjin Economic & Tech Dev Zone
300457, Tianjin
+
http://www.asymchem.com.cnSector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.24% | 3.91B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 002821 Stock
- Company Asymchem Laboratories (Tianjin) Co., Ltd.